San Diego-primarily based Viking Therapeutics marked itself as a significant competitor inside the weight loss drug market place in February immediately after revealing promising data from a mid-phase trial of experimental drug VK2735, which advised it rivaled—and outperformed—Novo and Lilly drugs when given as a weekly injection As well as in … Read More